Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
1100 Fairview Avenue North
Seattle, Washington 98109
206-667-4584 http://www.cancerconsortium.org/en.html
Seattle, Washington 98109
206-667-4584 http://www.cancerconsortium.org/en.html
The Fred Hutchinson/University of Washington Cancer Consortium is a research collaboration comprising Fred Hutchinson Cancer Research Center and its strong collaborators, the University of Washington, Seattle Children's, and the Seattle Cancer Care Alliance. The Consortium is recognized as an NCI-designated Comprehensive Cancer Center through its dedication to developing research programs, faculty, and facilities that will lead to better approaches to prevention, diagnosis, and treatment of cancer.
The Consortium brings together over 500 faculty with interests in basic science, clinical and translational research, public health sciences, and global health related to cancer.
We've found
31 trials
at this facility
Hematology, Oncology, Reproductive Clinical Trial
Updated: 3/18/2013
A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies
Status: Enrolling
Updated: 3/18/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/13/2012
Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma
Status: Enrolling
Updated: 11/13/2012
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
Updated: 3/23/2015
Computer-Guided Glucose Management Systems in Treating Patients With Hyperglycemia Who Have Undergone Blood and Bone Marrow Transplant
Status: Enrolling
Updated: 3/23/2015
Click here to add this to my saved trials
Hematopoietic/Lymphoid Cancer Clinical Trial
Updated: 2/13/2014
Brentuximab Vedotin After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Status: Enrolling,
Phase
I, II
Updated: 2/13/2014
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/28/2016
Ado-Trastuzumab Emtansine in Treating Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed by Surgery
Status: Enrolling,
Phase
I
Updated: 11/28/2016
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Fractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Participants With Acute Myeloid Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Updated: 1/22/2013
Clofarabine and Cytarabine in Treating Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes That Have Relapsed or Not Responded to Treatment
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/26/2013
Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic Melanoma
Status: Enrolling
Updated: 7/26/2013
Click here to add this to my saved trials
Immunology / Infectious Diseases, Neurology, Oncology Clinical Trial
Updated: 9/16/2014
Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer
Status: Enrolling,
Phase
II
Updated: 9/16/2014
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Updated: 4/19/2013
Bortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in Remission
Status: Enrolling
Updated: 4/19/2013
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Updated: 1/8/2013
Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia
Status: Enrolling
Updated: 1/8/2013
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Updated: 7/9/2012
Vorinostat, Azacitidine, and Gemtuzumab Ozogamicin in Treating Older Patients With Relapsed or Refractory Acute Myeloid Leukemia
Status: Enrolling
Updated: 7/9/2012
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Updated: 9/16/2013
Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease
Status: Enrolling
Updated: 9/16/2013
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 8/26/2013
Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant
Status: Enrolling
Updated: 8/26/2013
Click here to add this to my saved trials
Graft Versus Host Disease Clinical Trial
Updated: 3/5/2013
Brentuximab Vedotin in Treating Patients With Steroid-Resistant Acute Graft-Versus-Host Disease
Status: Enrolling
Updated: 3/5/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/28/2014
Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 7/28/2014
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Updated: 9/13/2013
Azacitidine in Treating Patients With Relapsed Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant
Status: Enrolling
Updated: 9/13/2013
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Updated: 2/24/2014
Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy
Status: Enrolling,
Phase
II
Updated: 2/24/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/7/2014
TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck
Status: Enrolling,
Phase
I
Updated: 7/7/2014
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/10/2012
Tosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Status: Enrolling
Updated: 12/10/2012
Click here to add this to my saved trials
Leukemia Clinical Trial
Updated: 11/6/2012
Panobinostat (LBH589) and Imatinib Mesylate in Treating Patients With Previously Treated Chronic Phase Chronic Myelogenous Leukemia
Status: Enrolling
Updated: 11/6/2012
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Updated: 8/21/2012
Bendamustine Hydrochloride and Idarubicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia or Myelodysplastic Syndrome
Status: Enrolling
Updated: 8/21/2012
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Updated: 7/25/2013
Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes
Status: Enrolling
Updated: 7/25/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 6/23/2014
Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By Surgery
Status: Enrolling,
Phase
I
Updated: 6/23/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 6/1/2016
Carbon-11 Acetate and Fluorine F 18 Sodium Fluoride PET as a Biomarker of Treatment Response in Patients With Hormone Resistant Metastatic Prostate Cancer
Status: Enrolling
Updated: 6/1/2016
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 5/11/2012
Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast Cancer
Status: Upcoming
Updated: 5/11/2012
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/15/2014
Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma
Status: Upcoming
Updated: 12/15/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/10/2015
Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies
Status: Upcoming,
Phase
I, II
Updated: 11/10/2015
Click here to add this to my saved trials
SYSTEMIC SCLERODERMA Clinical Trial
Updated: 5/7/2012
Low-Dose Conditioning Followed by Donor Stem Cell Transplant in Treating Patients With Severe Systemic Sclerosis
Status: Upcoming
Updated: 5/7/2012
Click here to add this to my saved trials